COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1786: Articles 17851-17860  | Next

An alternative approach for bioanalytical assay development for wastewater-based epidemiology of SARS-CoV-2
Tim, B., Jacobs, L., De Roeck, N., Van den Bogaert, S., Aertgeerts, B., Lahousse, L., van Nuijs, A. L. N., Delputte, P.
10.1101/2021.02.12.21251626 — Posted: 2021-02-16
Workplace measures against COVID-19 during the winter third wave in Japan: company size-based differences
Ishimaru, T., Nagata, M., Hino, A., Yamashita, S., Tateishi, S., Tsuji, M., Ogami, A., Matsuda, S., Fujino, Y.
10.1101/2021.02.14.21251716 — Posted: 2021-02-16
Community end-of-life care during the COVID-19 pandemic: Initial findings of a UK primary care survey
Mitchell, S., Oliver, P., Gardiner, C., Khan, D., Chapman, H., Boyd, K., Dale, J., Barclay, S., Mayland, C.
10.1101/2021.02.15.21251756 — Posted: 2021-02-16
ImplemeNting SARS-CoV-2 Rapid antigen testing in the Emergency wArd of a Swiss univErsity hospital: the INCREASE study
Caruana, G., Croxatto, A., Kampouri, E., Kritikos, A., Opota, O., Foerster, M., Brouillet, R., Senn, L., Lienhard, R., Egli, A., Pantaleo, G., Carron, P.-N., Greub, G.
10.1101/2021.02.10.21250915 — Posted: 2021-02-15
C-reactive protein guided use of procalcitonin in COVID-19
Houghton, R., Moore, N., Williams, R., El-Bakri, F., Peters, J., Mori, M., Vernet, G., Lynch, J., Lewis, H., Tavener, M., Durham, T., Bowyer, J., Saeed, K., Pollara, G.
10.1101/2021.02.10.21251350 — Posted: 2021-02-15
Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections in K-12 Schools and Universities
Bi, C., Mendoza, R., Cheng, H.-T., Pagapas, G., Gabutan, E., Khan, N., Hoxie, H., Holmes, K., Gao, N., Lewis, R., Wang, H., Neumann, D., Chan, A., Takizawa, M., Lowe, J., Chen, X., Kelly, B., Asif, A., Barnes, K., Khan, N., May, B., Wright, M., Chowdhury, T., Pollonini, G., Gouda, N., Guy, C., Gordon, C., Ayoluwa, N., Colon, E., Miller-Medzon, N., Jones, S., Hossain, R., Dodson, A., Wang, M., McGaskey, M., Vasileva, A., Seibel, S., Connolly, J., Esposito, M., Kim, J., Lincoln, A. E., Sikka, R., Wyllie, A. L., Berke, E. M., Libien, J., Pincus, M., Premsrirut, P. K.
10.1101/2021.02.09.21251464 — Posted: 2021-02-15
Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication and its comparison with SARS-CoV
Lui, V. C.-H., Hui, K. P.-Y., Babu, R. O., Yue, H., Chung, P. H.-Y., Tam, P. K.-H., Chan, M. C.-W., Wong, K. K.-Y.
10.1101/2021.02.10.21251458 — Posted: 2021-02-15
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
Redd, A. D., Nardin, A., Kared, H., Bloch, E. M., Pekosz, A., Laeyendecker, O., Abel, B., Fehlings, M., Quinn, T. C., Tobian, A. A.
10.1101/2021.02.11.21251585 — Posted: 2021-02-15
A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19
Rosoff, D. B., Yoo, J., Lohoff, F. W.
10.1101/2021.02.11.21251581 — Posted: 2021-02-15
CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults
Veenith, T., Fisher, B. A., Slade, D., Rowe, A., Sharpe, R., Thickett, D. R., Whitehouse, T., Rowland, M., Scriven, J., Parekh, D., Bowden, S. J., Savage, J. S., Richards, D., Bion, J., Kearns, P., Gates, S., on behalf of CATALYST investigators
10.1101/2021.02.10.21251478 — Posted: 2021-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).